Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1
FDA inspection history in Polepally, India, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Polepally, India.
Cited most
Across all Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1 observations on file
- 21 CFR 211.192Production record review1
The complete Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1 file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Polepally, India
One Form 483 · 2019 · 1 observation
Latest: Form 483, Sep 27, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-09-27 | 483 Form 483 | Polepally, India | 1 | $99 |
Investigators on these documents
About Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1
How many FDA Form 483s has Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1 received?
FDA Intel has 1 Form 483 on file for Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1; the most recent is dated Sep 27, 2019.
When was Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1 last inspected by FDA?
The most recent FDA inspection document on file for Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1 is a Form 483 dated Sep 27, 2019, for the site in Polepally, India.
What did FDA cite at Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1?
The regulations cited most in the observations on file for Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1 are 21 CFR 211.192 (Production record review), 1 time.